Apr 01, 2020 this patient page explains tumor lysis syndrome, how it affects the body, who is at greatest risk, how to recognize it, and measures to help prevent it or treat it. Identication of patients at risk for the development of tumor lysis syndrome is the most important in management so that prophylactic measures may be implemented before the initiation of therapy serum creatinine, blood urea nitrogen, sodium, potassium, calcium, phosphorous, ldh and uric acid levels should be determined before therapy and every. Feb 22, 2016 although such clinical tumour lysis syndrome is rare affecting 36% of patients with highgrade tumours, the mortality is as high as 15% and a third of patients require dialysis. Clinical tumor lysis syndrome ltlsandoneormoreofthefollowing. Tumor lysis syndrome american society of nephrology. May 04, 2015 tumor lysis syndrome is an oncometabolic emergency resulting from rapid cell death. It results from rapid lysis of tumor cells and release of intracellular materials into the bloodstream. Although there have recently been substantial developments in cancer chemotherapy, these may increase the risk of tls. How is hyperkalemia managed in tumor lysis syndrome tls. Usually occurs in patients with bulky, rapidly proliferating, and treatment responsive tumors. Health, general evidencebased medicine health care costs control heart kidney diseases care and treatment prevention medical care, cost of medical research medicine, experimental physicians practice rasburicase risk assessment seizures medicine tumor lysis. Tumor lysis syndrome symptoms, causes, guidelines and.
As a result, tls can pose potentially lifethreatening complications for the patient such as electrolyte imbalances, acute kidney injury aki, acidbase imbalances. Tumor lysis syndrome tls is a lifethreatening oncologic emergency. Tumor lysis syndrome definition of tumor lysis syndrome by. Changes in blood levels of uric acid, potassium, phosphorus. We identified 1615 tls cases among 4 330 807 case reports covering the period from the first. Presentation tumor lysis syndrome has been defined in the literature as occurring within 7 days of the initiation of treatment for malignancy, although it most often presents within 12 to 72 hours after starting chemotherapy.
When cancer cells break down quickly in the body, levels of uric acid, potassium, and phosphorus rise faster than the kidneys can remove them. Tumor lysis syndrome is a potentially fatal metabolic condition that occurs most frequently in patients with rapidly proliferating, bulky, chemosensitive tumors table 36. Tumor lysis syndrome tls describes the clinical and laboratory sequelae that result from the rapid release of intracellular contents of dying cancer cells. Tumor lysis syndrome tls was first described in 1929 by bedrna and polcak in patients with chronic leukemia. Tumor lysis syndrome usually presents within seven days of cancer treatment, and patients with preexisting renal insufficiency are at increased risk. In oncology and hematology, this is a potentially fatal complication. Clinicians should stratify every hospitalized cancer patient and especially those receiving chemotherapy for the risk of tumor lysis syndrome.
Tumor lysis syndrome tls is a cancer chemotherapyassociated oncologic emergency. Tumor lysis syndrome symptoms, causes, guidelines and treatment. Patients particularly at risk have treatmentsensitive tumours, renal impairment or volume depletion. Tumor lysis syndrome is a condition that tends to be precipitated after a cancer treatment. Tumor lysis syndrome american academy of pediatrics. Mar 21, 2012 identication of patients at risk for the development of tumor lysis syndrome is the most important in management so that prophylactic measures may be implemented before the initiation of therapy serum creatinine, blood urea nitrogen, sodium, potassium, calcium, phosphorous, ldh and uric acid levels should be determined before therapy and every.
Tumor lysis syndrome tls is one of the metabolic oncologic emergencies identified by the oncology nursing society. Tumor lysis syndrome definition of tumor lysis syndrome. Preventing tumor lysis syndrome ons journal cne activity april 2016 ons. Tumor lysis syndrome is a rare case that may happen rapidly or spontaneously. Although tls can potentially occur with any type of. Use of sodium bicarbonate for alkalinization of urine is currently not recommended for prevention and treatment of tumor lysis syndrome tls. Postmasters foundation in cancer care for the advanced practice. Jan 01, 2020 this syndrome is largely preventable, and certainly manageable, with prompt diagnosis and appropriate intervention. Tumor lysis syndrome refers to the constellation of metabolic disturbances that occurs when large numbers of neoplastic cells are killed rapidly, leading to the release of intracellular ions and metabolic byproducts into the systemic circulation. Pdf tumor lysis syndrome tls refers to the constellation of deranged metabolic. In this study, we aimed to identify anticancer agents that increase tls risk, as classified by a tls panel consensus, using the us food and drug administration adverse event reporting system. Intraoperative acute tumor lysis syndrome during laparoscopic splenectomy preceded by splenic artery embolization. Catabolism of the nucleic acids to uric acid leads to hyperuricemia. Excess phosphorus can sop up calcium, leading to low levels of calcium in the blood.
Jun 16, 2016 tumor lysis syndrome tls is a rare complication of oncologic treatments in solid tumors. Tls can occur as a result of cancer treatment or spontaneously. Tumor lysis syndrome in childhood malignancies drugs in context. Tls is characterized by the rapid development of hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia, and is potentially lifethreatening. Pdf tumor lysis syndrome tls is an oncologic emergency due to the rapid lysis of tumor cells and subsequent release of large amounts of. Tumor lysis syndrome following trastuzumab and pertuzumab. Tumor lysis syndrome is triggered by rapid, acute cell lysis caused by cancer treatment. Tumor lysis syndrome tls is the most common lifethreatening oncological emergency encountered by physicians treating children with lymphoproliferative malignancies. Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma. Tumor lysis syndrome an overview sciencedirect topics. Although optimal methods of risk classification and treatment have been difficult to define, uniform standards for management of the tumor lysis syndrome are. Usually occurs in patients with bulky, rapidly proliferating, and.
This is typically seen in hematologic cancers, but can be seen more rarely in solid tumor diseases. Tumor lysis syndrome hematology jama oncology jama network. Tumor lysis syndrome can occur as a consequence of tumor targeted therapy or spontaneously. As a result, tls can pose potentially lifethreatening complications. Tls can occur spontaneously before cancer treatment but is more common within a week of starting treatment.
Guidelines for the management of pediatric and adult tumor. Which patients are at the highest risk for tumor lysis. Discussion tumor lysis syndrome results when tumor cells release their contents into the blood after therapy or spontaneously. Jan 08, 2018 tumour lysis syndrome is an oncological emergency whereby the lysis or breakdown of vast numbers of cells leads to the release of their contents, which can have catastrophic consequences for the. Tumor lysis syndrome tls in adult patients md anderson. Tumor lysis syndrome tls in adult patients page 1 of 7. Tumor lysis syndrome tls is characterized by a group of metabolic derangements caused by the massive and abrupt release of cellular components into the blood after the rapid lysis of malignant cells. It can occur within a few hours of treatment, but it is most often seen 4872 hours 23 days after treatment starts. The tumor lysis syndrome is the most common diseaserelated emergency in children and adults with hematologic cancers. Tumor lysis syndrome risk factors, diagnosis, and management rebekah a. Furthermore, a secondary decrease in free calcium concentration due to. Tumor lysis syndrome tls is a constellation of metabolic abnormalities resulting. Tumour lysis syndrome usually occurs at the start of chemotherapy when a large number of tumour cells are destroyed.
Tumour lysis syndrome is an oncological emergency whereby the lysis or breakdown of vast numbers of cells leads to the release of their contents, which can. This patient page explains tumor lysis syndrome, how it affects the body, who is at greatest risk, how to recognize it, and measures to help prevent it or treat it. Tumor lysis syndrome tls is an oncology emergency that occurs as a result of rapid tumor cell breakdown and the consequent release of massive amounts of intracellular contents, including potassium, phosphate, and uric acid, into the systemic circulation. Stratify pediatric patients with cancer according to risk of developing tls. Tumor lysis syndrome hematology jama oncology jama. Pdf tumor lysis syndrome tls is an oncologic emergency. Tumor lysis syndrome is a potentially fatal metabolic condition that occurs most frequently in patients with rapidly proliferating, bulky, chemosensitive tumors. For claims with a date of service on or after october 1, 2015, use an. Oncology investigators provide perspectives on the prevention and management of tumor lysis syndrome. Tumor lysis syndrome is a constellation of metabolic disturbances that can occur as a potentially fatal complication of treating cancers, most notably leukemias or solid rapidlyproliferating tumours. Control of plasma uric acid in adults at risk for tumor lysis syndrome. This syndrome is largely preventable, and certainly manageable, with prompt diagnosis and appropriate intervention. Patients at high risk for the development of tumor lysis syndrome should be. Jun 01, 2018 tumor lysis syndrome usually presents within seven days of cancer treatment, and patients with preexisting renal insufficiency are at increased risk.
Tumor lysis syndrome tls is a serious, sometimes lifethreatening oncologic emergency caused by rapid and massive cellular lysis and subsequent release of tumor cell contents and cytokines into. Cancer cells killed by therapy treatment may spill intracellular contents which may then accumulate faster than eliminated causing electrolyte and metabolic disturbances resulting to tumor lysis syndrome. This may lead to electrolyte disturbances including hyperuricemia, hyperphosphatemia, hypocalcemia, and hyperkalemia. Pathophysiology of tumor lysis syndrome tumor lysis syndrome is caused by the rapid breakdown of tumor cells resulting in a sudden release of intracellular contents including anions, cations, and nucleic acids into the bloodstream. This occurs most commonly after the treatment of lymphomas and leukemias. Tls reports were retrieved from the faers database, and reporting odds ratios rors were used to estimate associations between tls and old and new anticancer agents or their combinations. Tumor lysis syndrome tls is a potentially fatal complication of induction therapy for several types of malignancies.
We report a case of tls which occurred after a single dose of trastuzumab and pertuzumab in the context of metastatic breast cancer in a chemonaive. These metabolic disturbances lead to lifethreatening conditions and may cause sudden. It is characterized by the release of potassium, phosphorous, and nucleic acids from cancer cells into the blood stream, with the potential to cause hyperkalemia. Tumor lysis syndrome is an oncometabolic emergency resulting from rapid cell death. After completing this article, readers should be able to. Clinically, the syndrome is characterized by rapid development of hyperuricemia,hyperkalemia, hyperphosphatemia, hypocalcemia, and acute kidney. Clinical tumor lysis syndrome requires the presence of laboratory tumor lysis syndrome plus an increased creatinine level, seizures, cardiac dysrhythmia, or death.
Prevention of tls may be more effective than treatment, and. Tumor lysis syndrome tls is an oncologic emergency that is caused by massive tumor cell lysis with the release of large amounts of potassium, phosphate, and nucleic acids into the systemic circulation. Although such clinical tumour lysis syndrome is rare affecting 36% of patients with highgrade tumours, the mortality is as high as 15% and a third of patients require dialysis. Tumor lysis syndrome tls is an oncologic emergency with a constellation of laboratory findings that result from the lysis of cancer cells. Tumors are also called neoplasms, which means that they are composed of new and actively growing tissue. This condition is a group of symptoms and a complication from cancer treatment. Patient information hematology oncology hematologic cancer lymphomas. Health, general evidencebased medicine health care costs control heart kidney diseases care and treatment prevention medical care, cost of medical research medicine, experimental physicians practice rasburicase risk assessment seizures medicine tumor lysis syndrome.
Tls is an oncologic emergency caused by the rapid and massive breakdown of tumor cells, either spontaneously or after the initiation of cytoreductive therapy. Tumor lysis syndrome tls is a rare complication of oncologic treatments in solid tumors. Catabolism of the nucleic acids to uric acid leads to hyperuricemia, and the marked increase in uric acid excretion can result in the. Dying cells release large amounts of potassium, phosphate, and uric acid into the blood. Tumor lysis syndrome inpatient care what you need to know. Tls is not limited to systemic chemotherapy, which travels throughout the body to destroy cancer cells.
Tumor lysis syndrome tls in adult patients page 1 of 7 disclaimer. Tumor lysis syndrome tls is a serious metabolic disturbance caused by the death of cancer cells during cancer treatment and the release of their intracellular components into the bloodstream. The identification and management of severe hyperkalemia. Journal of clinical oncology, 2827, 420742 larson, r. Tumor lysis syndrome following trastuzumab and pertuzumab for. This can cause heart or kidney problems and lead to kidney failure. Tumor lysis syndrome is a group of metabolic abnormalities that can occur as a complication during the treatment of cancer, where large amounts of tumor cells are killed off lysed at the same time by the treatment, releasing their contents into the bloodstream. Tls can become lifethreatening if is not managed or treated. This algorithm has been developed for md anderson using a multidisciplinary approach considering circumstances particular to md andersons specific patient population, services and structure, and clinical information.
1253 1501 538 46 570 1291 1047 783 486 1352 274 1620 1331 961 763 540 735 153 990 1398 705 706 482 1226 1279 867 1148 290 247 678